Catecholamine-uptake inhibitors prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse brain
- 1 July 1985
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 24 (7), 689-692
- https://doi.org/10.1016/0028-3908(85)90114-5
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Pharmacological interference with the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in the mouseEuropean Journal of Pharmacology, 1985
- VII. Studies on the mechanism of action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Life Sciences, 1985
- II. Selective accumulation of MPP+ in the substantia nigra: A key to neurotoxicity?Life Sciences, 1985
- Uptake of MPP(+) by dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin, MPTPEuropean Journal of Pharmacology, 1984
- Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitorsNature, 1984
- Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: Most antidepressants selectively block norepinephrine uptakeEuropean Journal of Pharmacology, 1984
- Behavioral properties of GBR 12909, GBR 13069 and GBR 13098: Specific inhibitors of dopamine uptakeEuropean Journal of Pharmacology, 1984
- Neurotoxicity of the meperidine analogue N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurons in the mouseEuropean Journal of Pharmacology, 1984
- Chronic parkinsonism secondary to intravenous injection of meperidine analoguesPsychiatry Research, 1979
- MOLECULAR-GEOMETRY OF INHIBITORS OF UPTAKE OF CATECHOLAMINES AND SEROTONIN IN SYNAPTOSOMAL PREPARATIONS OF RAT-BRAIN1976